Chiara Pircher
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 17
- Pancreatic and Hepatic Oncology Research 12
- Colorectal Cancer Treatments and Studies 2
- Cancer Immunotherapy and Biomarkers 2
-
- Renal cell carcinoma treatment 9
- Co-authors
- Claudio Doglioni (7 shared papers)Massimo Falconi (7 shared papers)Gianpaolo Balzano (7 shared papers)Michele Reni (8 shared papers)Luca Gianni (7 shared papers)Silvia Zanon (8 shared papers)Marta Chiaravalli (7 shared papers)Domenica Ceraulo (5 shared papers)
In The Last Decade
Chiara Pircher
19 papers receiving 389 citations
Chiara Pircher's Hit Papers
Peers
Comparison fields: 5 of 38
- Oncology 331
- Cancer Research 175
- Pulmonary and Respiratory Medicine 209
- Epidemiology 86
- Surgery 95
Countries citing papers authored by Chiara Pircher
This map shows the geographic impact of Chiara Pircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Pircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Pircher more than expected).
Fields of papers citing papers by Chiara Pircher
This network shows the impact of papers produced by Chiara Pircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Pircher. The network helps show where Chiara Pircher may publish in the future.
Co-authors
The 25 scholars most cited alongside Chiara Pircher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 166 | |
| 2 | 2018 | 54 | |
| 3 | NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer Hit paper breakdown → | 2024 | 47 |
| 4 | 2018 | 42 | |
| 5 | 2021 | 18 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 10 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 8 | |
| 10 | 2023 | 4 | |
| 11 | [Peritoneal lavage using polyvinylpyrrolidone iodide. Apropos of 11 cases]. | 1974 | 4 |
| 12 | 2016 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2025 | 0 |
About Chiara Pircher
Chiara Pircher is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Epidemiology, having authored 22 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (12 papers), Renal cell carcinoma treatment (9 papers), Neuroendocrine Tumor Research Advances (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Oncology (331 citations), Cancer Research (175 citations), Pulmonary and Respiratory Medicine (209 citations), Epidemiology (86 citations) and Surgery (95 citations). Chiara Pircher has collaborated with scholars based in Italy, Germany and France. Frequent co-authors include Claudio Doglioni, Massimo Falconi, Gianpaolo Balzano, Michele Reni, Luca Gianni, Silvia Zanon, Marta Chiaravalli, Domenica Ceraulo, Paolo Giorgio Arcidiacono and R. Castoldi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, The Lancet. Gastroenterology & hepatology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.